NRP1 and acute myeloid leukemia: NRP-1 percentage expression for all AML cases was 25.9±17.2% taking all patients as a single group, 27.1±17.5% in the group of patients with de novo AML, and 21.5±16.6% in the group of patients with relapsed AML.